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Bear bile has been awell-knownChinesemedicine for thousands of years. Because of the endangered species protection, the concept
on substitutes for bear bile was proposed decades ago. Based on their chemical composition and pharmacologic actions, artificial
bear bile, bile from other animals, synthetic compounds, and medicinal plants may be the promising candidates to replace bear
bile for the similar therapeutic purpose. Accumulating research evidence has indicated that these potential substitutes for bear bile
have displayed the same therapeutic effects as bear bile. However, stopping the use of bear bile is a challenging task. In this review,
we extensively searched PubMed and CNKI for literatures, focusing on comparative studies between bear bile and its substitutes
for the treatment of liver diseases. Recent research progress in potential substitutes for bear bile in the last decade is summarized,
and a strategy for the use of substitutes for bear bile is discussed carefully.
1. Introduction
Bear bile is the dried gallbladder bile collected from the
black bear (Selenarctos thibetanus), the brown bear (Ursus
arctos), or other species of Ursidae, under the category of
animal drugs in Traditional Chinese Medicine (TCM), and
has been used in TCM clinical practice for thousands of
years [1–3]. Among the classic prescriptions of TCM, there
are 396 kinds of prescriptions containing bear bile constitute
[4]. In the point of TCM view, bear bile is a cold medicine
and is bitter in flavor and cool in nature, and it is entering
meridian of liver, gallbladder, and heart, so it could clear heat,
relieve toxin, clear away liver fire, and stop endogenous wind
[5, 6]. In recent decades, modern pharmacological studies
also claimed that bear bile has a wide range of pharmaco-
logical actions, including hepatoprotection and antibacterial,
antiviral, anti-inflammation, antigallstones, hypolipidemic,
and some other effects [7–10]. In TCM clinical practice, bear
bile was used in fever fighting, detoxification, and reduction
of inflammation, swelling, and pain [4, 5]. Particularly, it was
widely used for curing a variety of liver diseases, such as
fibrosis, biliary cirrhosis, and even liver cancer [6]. Bear bile
shows strikingly abilities to reduce liver fire and liver heat,
which refer to the pathological phenomenon within the liver
from the point of Chinese medicine view.
However, the application of bear bile has drawn sub-
stantial concerns and controversy from worldwide public,
media, and animal rights folks. The first concern is that
the extensive consumption of bear bile in China and other
Asian countries has made bears become endangered species.
Although bears are listed in the Convention on International
Trade in Endangered Species of Wild Fauna and Flora
(CITES), the illegal abuse of innocent bear for huge profits
worldwide is continuing [3, 11–13]. The second concern is
the extreme cruel and inhuman method to extract bile from
living bear. The extraction method named “Free-dripping
Fistula Technique” by inserting a catheter into the bear
gallbladders to drain the bile daily was applied in thousands
of bear bile extraction factories [14, 15]. It once was thought
to be a great technological progress from “kill the bear to get
the bile” to “drain bile from living bear.” But the extraction
of bile from living bear is such an unbearable torture, which
does not kill the bear in an instant but will render it a pain
worse than death.The bears would suffer tremendous mental
stress and physical trauma for decades and result in illnesses
and chronic infections caused by the presence of foreign
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Figure 1: The chemical structure of bile acids in bear bile.
bodies and wounds [4, 16]. The third concern is the lasting
controversy of whether the use of bear bile is unsubstitutive
as it was claimed. Certain TCM physicians declare that there
is no alternative product which can substitute bear bile in
terms of its integrative effect. However, by a great number
of modern pharmacological and chemical investigations,
increasing drugs and compounds are considered to be the
substitute for bear bile [14, 15, 17].
Actually, the usage of bear bile is a complex issue con-
cerned with culture, economy, and even politics. The reasons
underlying the issue may merely be caused by not only the
imperfection of legal protection against bear but also the
biased belief of people that expensive and uncommon drugs
are associated with better effects. Facing these challenges, in
recent years, accumulative systematic researches on seeking
substitute of bear bile have been carried out bymany research
groups. It might be a struggling objective to replace the bear
bile by artificial material with the same composition, but it
is possible to provide scientific evidences of the comparable
curative effect of potential substitute [11, 12]. Artificial bear
bile, bile from other animals, synthetic compounds identified
from bear bile, and some herbs from TCM are regarded as
the most promising substitutive materials for bear bile [4].
A rational way to protect the endangered bears and stop the
abuse of bear bile requests is not only comprehensive research
in definite composition and pharmacological actions of bear
bile but also comparative research in treatment efficiency of
the probable substitute [15, 18]. In this review, the research
progress of bear bile and its potential substitute in last decade
will be updated, and predominant attentionwill focus on liver
diseases. Furthermore, challenge ahead for the realization of
substitute of bear bile will be discussed thoroughly.
2. Recent Research Progress in Bear Bile
2.1. Composition of Bear Bile. During past decades, extensive
research has been performed to qualify and quantify the
composition of bear bile, especially the total and individual
bile acids. Modern chemical research indicated that bear
bile was composed primarily of bile acids, phospholipids,
cholesterol, bile pigments, proteins, and inorganic salts [19].
Among these components, bile acids may play a major role
in therapeutic action for bear bile. Bile acids are synthesized
from cholesterol by the hepatocytes and are concentrated and
stored in the gallbladder [7, 11–13]. All the bile acids in bear
bile are in the form of taurine conjugate, including tauro-
cholic acids (TCA), tauroursodeoxycholic acids (TUDCA),
taurodeoxycholic acids (TDCA), and taurochenodeoxycholic
acids (TCDCA), which are shown in Figure 1. These conju-
gated bile acids are formed through the conjugation of amino
acid taurine with each of the corresponding free bile acids.
In a survey study, the contents of two major constituents,
TUDCA and TCDCA, in 8 commercial batches of bear bile
were detected as 39.04±7.83%and 36.10±9.42%, respectively
[20]. The average concentrations of TUDCA, TCDCA, and
TCA in 93Ursidae bile salts were 3087.8±1626 𝜇g/mL, 1968±
678.1 𝜇g/mL, and 212.6 ± 154.1 𝜇g/mL, respectively [21]. Of
note, it is believed that the relative high level of TUDCA and
TCDCA makes bear bile different from biles derived from
other animals [4, 15, 19].
However, the composition of bear bile is not constant;
instead, it changed by a variety of factors, such as existing
style, species, physical state, and season. It has been reported
decades ago that a remarkable reduction of TCA and a
dramatic increase of TUDCA and TCDCA were detected
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in the bile which is originated from farmed bears [19]. In
terms of the differences between species, it was found that
the content of TCA in North American and polar bears
was higher than that in Asiatic bears [21]. The seasonal
change of the composition in bear bile was also observed.
In a study, the composition contents of gallbladder from 8
active and 14 dormant black bears were analyzed by HPLC.
The proportion of TUDCA to the sum of the TUDCA,
TCDCA, and TCA was decreased and the concentrations
of cholesterol, phospholipids, and metals including calcium,
magnesium, zinc, and copper were increased. The results
indicated that a striking decrease of metabolic activity in the
gut flora is kind of adaptation to metabolic stability of the
dormant bear [20–22]. In practice, the variation of bile bear
composition is crucial and worth noting, which is of great
importance to identify the quality of bile.
Furthermore, some new compounds were identified and
isolated in bear biles recently. Two new bile acids, taurose-
locholic acid and tauroansocholic acid, and a new natural
bile acid, cygnocholic acid, were isolated from bear bile
powder [23, 24]. Several flavone compounds were also
identified in bear bile, including 4󸀠,7-dihydroxyisoflavo-
ne, 4󸀠,7-dihydroxy-6-methoxyisoflavone, 4󸀠,6,7-trihydroxy-
isoflavone, and 4󸀠-methoxy-7-hydroxyisoflavone [22]. The
identification and isolation of new compounds may provide
scientific basis to further investigate their pharmacological
actions and mechanisms.
2.2. Pharmacologic Effects and Clinic Application. Modern
pharmacological studies confirmed that bear bile powder
has a variety of physiological activities, such as antibacterial,
antipyretic, sedative, anti-inflammatory, antispasmodic, anti-
convulsants, antistress, dissolving gallstones, hypoglycemic,
and antitumor effects. It also shows some effects on the
cardiovascular system, which can lower blood glucose and
lipids, relax blood vessels, and inhibit thrombosis [25–30]. In
TCM clinical practice, bear bile was used in fever fighting for
seasonal febrile disease, detoxification, heat-toxin syndrome,
and reduction of inflammation and pain. Besides traditional
use, the modern application of bear bile was spread widely
to many modern diseases based on traditional indications
and pharmacological effects. Clinically, modern medicine
extensively applies bear bile to eye disease, hemorrhoids
and gallstones, bile reflux gastritis, viral hepatitis, gallstone
pancreatitis, fatty and alcoholic liver disease, drug-induced
hepatitis, and other cholestatic liver diseases. In terms of eye
disease induced by overbalance of liver fire and heat-toxin,
bear bile shows remarkable therapeutic effect. Xiongdan
Eyedrops made by bear bile is a famous drug to treat eye
disease. From Chinese medicine perspective, it is believed
that the eyes act as the window of the liver; therefore, the
specific effect of bear bile on eye disease also implies its
outstanding application in liver disease.
3. Bear Bile in Liver Diseases
As bile is predominantly produced by hepatocytes to digest
fat, it plays an important physiological and pathophysiolog-
ical role in the body. The lack or disorder of bile, especially
for bile acids and bile salts, causes fat digestion problems and
related hepatobiliary diseases. It is believed that exogenous
administration of animal biles to supply bile compositions
could attenuate these diseases. Clinically, bear bile is widely
used not only for hepatobiliary diseases but also for other
liver diseases, such as viral hepatitis, fibrosis, or liver cancer
[12–14, 16, 31–36]. In traditional clinical practice, bear bile was
used in the cure of overabundance of liver fire and redness of
eyes due to liver heat. Although it indeed shows positive ther-
apeutic effect to a certain extent, the mechanisms concerning
how it works still have not been fully elaborated. Generally,
people attribute the hepatoprotective effects of bear bile to its
immunity enhancement and microenvironment regulation
abilities [7, 11, 12].
The comprehensivemetabolomics profiling and pathways
in animal models with hepatitis C virus (HCV), a leading
cause of liver disease worldwide, have been investigated in
a study. It was found that the proteins of bear bile powder,
a widely used anti-HCV drug, could relieve HCV infection
partially by modulating the perturbed pathway, but the
specific mechanism and pathways are not clear until now
[30]. With regard to alcoholic injury, bear bile additionally
showed protective effects [31]. Protective effect of bear bile
powder on alcohol-induced oxidative damage in mouse
primary cultured hepatocytes was also demonstrated [31]. It
has also been indicated that bear bile possesses inhibitory
efficacy against the suppressive immune activity induced by
hepatic stellate cells [32, 33].The immunosuppression activity
induced by hepatic stellate cells in the injured liver plays
a vital role in the pathogenesis of liver disease, including
fibrosis and hepatocellular cancer. Bear bile could decrease
the population of hepatic stellate cells, regulate the surface
molecules, and thus affect the related cytokine secretion.
Furthermore, hepatic stellate cells isolated from the mice
treated with bear bile can promote the proliferation of T cell,
decrease regulatory T cells, and enhance the activation of T
cells, which means bear bile may improve immune response
in liver disease [34–36].The research of our group also proved
that bear bile derived from Asiatic black bear showed effects
at a certain level on the fibrosis induced by different factors,
including CCl
4
, bile duct ligation, and alcohol [15].
In addition to the above liver diseases, the effect of bear
bile on liver cancer has been broadly studied in diverse
models. It was demonstrated that bear bile powder could
inhibit the growth of HepG2 hepatocellular cancer cells in
a dose-dependent manner through activation of caspase-
9 and caspase-3 and thus leads to cell apoptosis [37]. In
a nude mice hepatocellular carcinoma xenograft model, it
was found that bear bile could induce the apoptosis of
cancer cells and inhibit their proliferation by upregulating the
expression of Bax and inhibiting the protein expression of
Bcl-2, PCNA, p-STAT3, CDK4, and cyclin D1 [38]. In terms
of liver cancer induced by diethylnitrosamine, bear bile could
prevent the progress of hepatocarcinoma in ratmodels, which
may be related to its inactivation of hepatic stellate cells,
and thereby alleviate fibrosis and cirrhosis [39]. Additionally,
the combined treatment of bear bile powder and cyclophos-
phamide shows protective effect on colorectal cancer liver
metastasis by increasing immunity and regulating tumor
4 Evidence-Based Complementary and Alternative Medicine
microenvironment, particularly, by reducing inflammatory
cell infiltration [40].
4. Substitute of Bear Bile
Actually, the concept of substitute of bear bile has been raised
for decades since people realized the miserable situation of
bear bile. Looking for substitute of bear bile means finding a
kind of material which does not originate from endangered
species and possesses similar therapeutic effects to those of
bear bile to replace the clinical use of bear bile [15]. A basic
principle for substitute of bear bile is the similar chemical
or pharmacological profiles. In this respect, four kinds of
substitutes for bear bile are considered: (1) artificial bear bile,
(2) synthetic compounds, (3) other animal biles, and (4)
medicinal plants [4, 11, 12]. In addition to fitChinesemedicine
view, modern systematic research has to be performed to
provide scientific evidences for an alternative of bear bile.
4.1. Artificial Bear Bile. Artificial bear bile is the counterfeit of
natural bear bile, which contains almost similar compositions
and structures of various synthetic or natural bile acids,
amino acids, minerals, cholesterol, and bilirubin to the
natural ones. In fact, artificial bear bile contains almost all the
active ingredients contained in high-quality natural bear bile,
and the content is very close [41]. TUDCA, which is a specific
compound that has been only discovered in bear bile so far
and does not appear in the other animal bile samples, was
also detected in artificial bear bile, which reduces apoptosis
by modulation of AP-1 and shows anticholestatic effect [42–
44]. In certain cases, the content and stability of the active
compounds are even high and better than drainage bear bile.
The similar chemical composition constructs the basis of
its comparable pharmacologic effects to those of bear bile
[4, 15]. Meanwhile, research has pointed out that artificial
bear bile has shown similar efficacy to natural bear bile, such
as antibacterial, anti-inflammatory, and antispasmodic effects
[41]. Hundreds of clinical trial results indicated that, in the
treatment of artificial bear bile on acute tonsillitis and anger
hyperactivity hypertension, artificial and natural bear bile
show no significant difference in efficacy.
Although artificial bear bile displays strong competitive-
ness and potential as substitute of bear bile, totally replacing
the natural and drainage bear bile with artificial bear bile
is a long way to go. Despite challenge ahead, the success-
ful application of some substitutes of traditional expensive
Chinese medicine drugs, such as artificial tiger bone used to
replace tiger bone, still leads to enthusiasm for the possibility
of replacing bear bile with artificial bear bile.
4.2. Synthetic Compounds. Among the chemical components
in bear bile, bile acids were regarded as the main effective
components; among the bile acids, UDCA and TUDCA
have attracted most attentions. As a matter of fact, UDCA,
which is named from the root word for bear, urso, was
first discovered in bear bile in 1900s. Of note, in humans,
UDCA is a second bile acid, which is the metabolite of
primary bile acid by intestinal microbiota; whereas in bears,
it is made directly from cholesterol by hepatocytes and then
conjugates with taurin to form TUDCA. Theoretically, it is
believed that UDCA exists in bear bile with relatively low
content; however, several studies that aimed to determine
the composition of bear bile revealed that UDCA was not
detected by modern chromatography technique [19, 45],
which might be due to the limit of detection or the status
of bear. This controversy is of great importance and is worth
noting because UDCA shows remarkable pharmacologic
action and was traditionally considered to be the primary
bioactive component of bear bile.
UDCA, which is hydrophilic unlike other common bile
salts, significantly relieves liver damage in the setting of
cholestasis [46–49]. In 1950s, it was synthesized successfully
and adopted to treat liver diseases clinically [50]. Clinical
studies have confirmed the beneficial effects of UDCA in a
broad variety of cholestatic liver diseases, including primary
biliary cirrhosis, pediatric cholestatic disorders, primary
sclerosing cholangitis, and drug-induced cholestasis [51–
55]. It is assumed that UDCA replaces the more detergent
and potent endogenous dihydroxy bile acids within the bile
acid pool, principally by inhibiting their active absorption
from the intestine [56, 57]. In addition, UDCA also pro-
motes membrane insertion of transporters for biliary lipid
at the level of the hepatocyte canaliculus [48, 50]. High-
dose UDCA (28–35mg/kg per day) was administered to
patients with nonalcoholic steatohepatitis; the normalized
aminotransferase levels, reduced serum fibrosis marker, and
improved markers of glycemic control and insulin resistance
were observed, which revealed thatUDCA is an ideal drug for
nonalcoholic steatohepatitis [57, 58]. For liver injury induced
by drug, UDCA also shows respectable therapeutic effects
[59, 60]. Additionally, with regard to hepatectomized liver
transplantation model and hepatocellular carcinoma, UDCA
could relieve the hepatic damage [61–63]. Of note, UDCA
is the only drug for patients with primary biliary cirrhosis
which is approved by the Federal Drug Administration. Since
UDCA has not been detected in bear bile by modern studies
whereas it has been confirmed that it possesses outstanding
pharmacological functions, the replacing of bear bile in liver
disease by synthesized UDCA is rational and promising. The
synthesis technology successfully meets the demands of large
quantities of UDCA for medicine use [64].
TUDCA, the specific bile acid in bear bile, is also a
hydrophilic bile acid that is synthesized in the conjugation
pathway of UDCA, which acts as bile secretagogues and
immunomodulators [65, 66]. In addition to cholestatic liver
diseases, TUDCA shows hepatoprotective effects during
long-term ethanol feeding and ischemia-reperfusion injury
[67, 68]. It can prevent apoptosis in hepatic and nonhepatic
cells induced by various factors, such as hydrophobic bile
acids, Fas ligand, transforming growth factor 𝛽1, and alco-
hol [68, 69]. The mechanisms involved include improving
mitochondrial function and integrity and interactions with
NF𝜅B pathways [69]. The synthesized TUDCA, which has
been produced and used as drug and supplement, to say
the least, partially represents the effective component of
pharmacological action of bear bile. Therefore, TUDCA
could replace the use of bear bile in many contexts.
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In addition to UDCA and TUDCA, several other bile
acids are extensively studied for their pharmacological effects.
DCA, one of the secondary and free bile acids, are metabolic
byproducts of CDCA by intestinal bacteria. The main func-
tion of DCA is to dissolve gallstones. The generation of
gallstones is due to oversaturation of cholesterol in the bile,
forming a rock after precipitation, while DCA could inhibit
reabsorption of cholesterol in the intestine and blockage
of cholesterol to bile secretion, thereby reducing the con-
centration of cholesterol in the bile [4, 6, 19]. It has been
indicated that CDCA, an isomer ofUDCA, could improve the
composition of bile and increase the solubility of cholesterol
with less toxic side effects [70]. It was also found that it
could upregulate the expression of fibroblast growth factor 21
in liver of C57/BL6 mice, resulting in a decrease in plasma
triglyceride, cholesterol, and blood glucose [71]. A study
performed by our group showed that the cytotoxic activity of
DCA, CDCA, and TCDCA on liver cancer cells MHCC97-L
is better than that of bear bile, which gives a hint that they
might be an alternative to bear bile in prevention of liver
cancer and as a therapy for the same [19]. With regard to
HDCA, it is a kind of specific deoxycholate extracted from
pig, whose structure is slightly different from that of UDCA.
The function of HDCA is close to that of UDCA, showing
significant ability to lower blood cholesterol [6].
As mentioned before, accumulating scientific evidences
demonstrated that these bile acids are suitable to replace the
usage of bear bile in medicine, especially in terms of chronic
liver disease. In fact, the successful synthetic technique of
these DCA-based acids not only meets the need in quantity
but also provides more stable quality of drugs. As of today,
most of bear bile products are made by biles extracted
from living bears, which always get infected from the open
wound [4].The replacement of synthetic bile acid compounds
might effectively solve these drawbacks of bear bile, including
unstable composition and poor quality control. However,
concern might be raised that single compound could not
exert integrative effects, which is pursued and highlighted
in Chinese medicine. The combination of several active
components could be considered in the future.
4.3. Biles from Other Animals. In TCM, it is believed that
drugs with similar efficacy and taste generally have a certain
similarity of pharmacological properties, which gives a hint
that they might be used alternatively [4, 72]. For example,
buffalo horn clinically is often used instead of rhinoceros
horn, thus solving the contradiction between endangered
rhino protection and medicinal usage. In the same respect,
other animal biles have highly possible potential to be the
substitutes of bear bile. Extensive studies have been con-
ducted to investigate the differences and similarities between
bear bile and other animal biles in terms of composition and
pharmacological actions.
Plenty of studies have been carried out to compare the
compositions of biles derived from other animals with bear
bile; particularly attention was paid to bile acid due to its vital
role in pharmacological activities.The bile acid compositions
of several animals, including snake, pig, cattle, chicken, and
rabbit, were preliminarily studied to compare with bear biles
Table 1: The presence of various bile salts in some animal biles [72–
75].
Animal Bile salts
Bear TUDC, TC, TDC, TCDC
Dog TC, TCDC, TDC
Cattle TC, TDC, TCDC, TLC, GC, GDC, GCDC,GLC, AC
Pig TC, TDC, TCDC, THC, THDC, GC, GDC,GCDC, GHC, GHDC, GHOC
Snake TPC, TC, TDC
Rabbit GDC, TC, TDC, TCDC
Chicken TC, TCDC, TAC
Fish TCDC, TC, TDC, AC
Goose TCDC, TPHC, TBC
Duck TCDC, TPHC, TBC
Mouse TC, TDC, TCDC, T-𝛽-MC, T-𝜔-MC, TUDC
TUDC: tauroursodeoxycholate; TC: taurocholate; TDC: taurodeoxycholate;
TCDC: taurochenodeoxycholate; TLC: taurolithocholate; GC: glycocholate;
GDC: glycodeoxycholate; GCDC: glycochenodeoxycholate; GLC: glycol-
ithocholate; AC: allocholate; THC: taurohyocholate; THDC: taurohyodeoxy-
cholate; GHC: glycohyocholate; GHDC: glycohyodeoxycholate; GHOC:
glyco-3𝛼-hydroxy-6-oxo-5𝛽-cholate; TPC: tauropythocholate; TAC: tau-
roallocholate; TBC: taurobitocholate; TPHC: taurophocacholate; T-𝛽-MC:
tauro-𝛽-muricholate; T-𝜔-MC: tauro-𝜔-muricholate.
[19, 73]. Remarkably, the variants of chemical composition
of the animal bile were observed. Pig bile contained a great
deal of UDCA, whose taurine conjugated form is TUDCA.
Snake bile acid was primarily comprised of TCA and rabbit
bile contained a great deal of glycodeoxycholic acid (GDCA),
whereas cattle bile acid mainly consisted of DCA, CDCA,
and TCDCA, a series of DCA-based chemicals. The presence
of various primary bile salts, which change into bile acids
in acidic conditions in common animal biles recorded in
traditional Chinese medicine, was listed in Table 1 [6, 19, 72–
75]. As seen from Table 1, many other animal biles contain
TC, TDC, and TCDC, as bear bile does. TUDC, as specific
compound in bear bile, is also present in mouse bile, which is
worth to be further studied [73].
Meanwhile, in addition to the comparison of composi-
tions of bile acids, increasing comparative researches to study
the pharmacologic actions of different animal biles have been
carried out. Many pharmacologic actions of the rabbit bile
and cattle bile were similar to those of bear bile and even
stronger than those of bear bile in terms of some effects, such
as antihistaminic and antitussive abilities [6, 76, 77]. With
regard to the relief of hepatocyte injury induced by CCl
4
,
the therapeutic effect of rabbit bile was as good as that of
bear bile. For pig bile, it was reported that both bear bile
and pig bile possess comparable bioactivities, such as anti-
inflammatory and analgesic effects [4, 6]. Furthermore, it has
been indicated that pig bile possesses antiallergic effect on
delayed-type hypersensitivity, a feature shared with bear bile
but not with cattle, which might be due to the presence of
UDCA. The cytotoxic effect of bile from bear species and
other several animals on the hepatocellular carcinoma cell
line MHCC97-L was tested using the MTT assay in our
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group. Our results indicated that biles from pig and cattle
showed potent cytotoxic effects in MHCC97-L cells, which
were notably better than that of bear bile [15]. These several
kinds of biles were generally regarded as the most promising
substitutes of bear bile based on the constitute compositions
and pharmacological effects.
Since the function and chemical composition of many
other biles have certain similarity to bear bile, bile acids
derived from other animals provide great prospect for the
development of bear bile substitutes. Certainly, it is not
acceptable to transfer the miserable destiny from bear to any
other animals. In fact, the substitute for bear bile from other
animals remains controversial concerning the animal welfare
and animal rights. InChina, for themost livestock such as pig,
cattle, and duck, their internal organs including gallbladders
will be abandoned after slaughter [6]. In this case, using biles
from livestock as alternatives of bear bile not only protects
endangered species and prevents crucial extraction but also
avoids the waste of resources.
4.4. Traditional Medicinal Plants. Traditional Chinese me-
dicinal plants are abundant resources to look for alternatives
for bear bile. Actually, searching for substitutes of rare and
expensive traditional drugs in Chinese medicinal plants has a
long history andmany successful cases have been created, for
example, Dangshen (Codonopsis pilosula (Franch.) Nannf.)
and Xiyangshen (Panax quinquefolius L.) as substitutes for
Renshen (Panax ginseng C. A. Mey.). The declaration that
“bear bile cannot be replaced” is made on the basis of
integrative effects highlighted in Chinese medicine; however,
alternative Chinese medicinal plants have the potential to
reach integrative treatment efficacy from Chinese medicine
view. In TCM, bear bile was characterized under the category
of clearing heat and detoxification drugs [6, 7, 11, 12].
Therefore, those Chinese herbs under the same category are
the first objects for consideration to be substitutes of bear
bile [78]. Chinese herbs with the efficacy of clearing heat
and detoxification are listed in our previous published paper
[4]. For example, Scutellaria baicalensis Georgi has been
studied as the herbal alternatives to bear bile, which shows
effects on IL-6 promoter and CYP3A4 activities [79]. But it
is regrettable that until now no study has been carried out to
systemically compare their pharmacological effects with that
of bear bile by modern scientific research methodology.
Among the promising plant alternatives for bear bile,
Coptis, “Huanglian” in Chinese, is an outstanding candidate.
Seen from TCM view, both bear bile and Coptis are under the
category of clearing heat and bitter taste; moreover, both of
them could detoxify and purify liver and improve eyesight
according to Chinese medicine theories. In TCM clinical
practice, they have similar clinical indications and are often
used to treat liver diseases [80, 81]. In our group, extensive
researches have been performed on the pharmacological
actions ofCoptis and its main bioactive compound berberine.
By our past researches, it could be concluded that Coptis
and berberine possess convincing and satisfactory effects
on the treatment of various liver diseases, including acute
and chronic liver injury induced by CCl
4
, alcohol, bile
duct ligation, fibrosis, and liver cancer [82–86]. Strikingly,
a comparative study to investigate the therapeutic effects
of bear bile and Coptis extract on liver fibrosis in rats
has been conducted by our group. Apart from that, the
hepatoprotective actions of their main bioactive compounds,
TUDCA and berberine, respectively, are also compared. The
results we obtained are interesting and not disappointing.We
found that the effects of berberine and Coptidis Rhizoma to
treat fibrosis aremuch better than that of bear bile in the same
experimental condition. It was shown that berberine and
Coptidis Rhizoma could upregulate the activity of superoxide
dismutase (SOD), reducing oxidative stress. The reduced
serum total bilirubin levels indicated that berberine was able
to excrete the bilious product and prevent the hepatocyte
injury [15]. These results throw light on using berberine
as substitute of bear bile to treat diverse liver diseases
including cholestatic and noncholestatic liver fibrosis. But the
disadvantage of plants substitution also exists. Substitution
with totally different compositions makes it hard to explain
the similar medicinal effects by modern research.
5. Challenge Ahead and Strategy
5.1. Scientific Research. Although accumulating researches
have shown positive results for the development of sub-
stitute of bear bile, more convincing data from modern
basic research and clinical study are required [15]. Regret-
tably, there are only few systematic and scientific researches
which had been performed to compare the medicinal effects
between potential substitutes and bear biles. For instance, the
medicinal effects of UDCA andTUDCA, which are treated as
the primary effective components in bear bile, are supposed
to be compared with bear bile in the same condition. For
basic research, apart from effect, the mechanism of bear bile
and its main bioactive compound should also be investigated.
By knowing how it works in vivo to exert medicinal effect,
more targeted substitutes could be noted and attempted.With
regard to clinical study, an indispensable part to realize the
replacement of bear bile, trials with large-scale patients on
the medicinal effects of substitute of bear bile should be
designed and conducted. People who insist on their belief
that bear bile could not be replaced with Chinese medicine
are also supposed to provide scientific evidences to prove it.
The debate of bear bile and substitute might be solved by
rational research data [4, 6]. With only sufficient scientific
evidences provided, people might change their traditional
mind and have faith in bear bile substitute. Besides the
interest and awareness of endangered species protection,
sufficient financial support is vital to carry out these studies.
5.2. Government and Policy. Government, which makes the
policy, plays an extremely important role in the development
of bear bile substitute. Actually, with regard to Chinese
government, whether bear bile should be used or not is
a dilemma. On one hand, bear bile is a part of Chinese
medicine and is also a part of traditional national culture,
which is supposed to be preserved and cherished. On the
other hand, there was constant pressure from animal protec-
tion groups both at home and abroad [4]. How to balance the
contradiction between traditional culture preservation and
Evidence-Based Complementary and Alternative Medicine 7
animal rights protection is a challenge ahead. Encouragement
and support for the development of bear bile substitute,
especially in terms of common livestock biles and traditional
Chinese medicinal plants, may help solve this contradiction.
As we mentioned above, artificial bear bile, which has been
demonstrated to possess the potential to replace the use of
bear bile several decades ago, still has not been approved
for marketing so far. The reason for this justified by related
department is puzzling and mainly involved profits. The
approval of artificial bear bilemay reduce themarket demand
on natural bear bile, thereby affecting the great profits made
frombear bile industry. But nomatter how, people should not
sacrifice the innocent bears only for self-profits and ignore
inhumanity andwild sources protection. Indeed, government
has the responsibility to preserve national culture; therefore,
supports seeking potential substitutes for bear bile rather than
simply prohibition are preferred. In the future, administrative
department should be more prudent in approving the bear
bile derived product in order to reduce the usage of bear bile
to a large extent. Furthermore, policy systems to protect and
support the research and development of substitute of bear
bile should be considered [6, 14].
5.3. Public, Media, and Other Organizations. In addition to
scientists and government, public, media, and other orga-
nizations could also contribute to the realization of bear
bile substitute. As of today, media is a powerful strength
and we should take full advantage of it for the progress of
bear bile substitute. In fact, it was the media that exposed
the miserable lives of bears in the cage for bile extraction,
which attracted wide attention from the public afterwards. A
company namedGui Zhen Tang, whichmainly runs business
in bear industry, attempted to be a listed company and
seems to get supports from government and Association of
Chinese Medicine in 2012. By the intensive condemnation
and protests from the public and mass media, finally, the
review process was suspended in 2013. In this case, the public
andmedia play a very important role in the protection of bear
bile, which in turn promotes the development of bear bile
substitute [4]. Apart from exposure, the media promotion of
substitutes for bear bile to the public is of importance. To
this day, plenty of people still have blind faith in rare and
expensive traditional drugs due to history and traditional
culture. People should get the point that getting bear bile
from living bears failed to protect bears; conversely, they
are subjected to incredible pain and suffering. Changing the
mind of people to accept the substitute of bear bile is the first
step, of course, which needs convincing scientific evidences
to support [15]. Given that using bear bile is a part of Chinese
culture and existing TCM practice, some people insist that,
no matter how close those substitutes can be, they are still
not as good as the real ones. Completely replacing real one
in bear bile chemical compositions is really difficult, but
pharmacological effect of the substitute which is better than
real bear bile is possible and real. With regard to other related
organizations, such as animal protection organization and
Non-Government Organization, they are supposed to offer
education, appropriate guidance, and surveillance to protect
bears and publicize the promising substitutes.
6. Conclusion
In conclusion, the development of bear bile substitute
depends on the collaboration and efforts ofmany aspects.The
use of substitutes is a very prudent issue, which needs per-
suasive research data, strict examination, and quality control.
Although increasing scientific evidences have demonstrated
that artificial bear bile, several kinds of animal biles, synthetic
compounds, and medicinal plants have the potential to sub-
stitute bear bile, it will take long time to stop the use of bear
bile with lots of struggles and challenges. Overall, scientific
comparative research, policy support, and promotion of the
substitutes are rational and indispensable strategy to realize
the replacement gradually in the future.
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